• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有丝分裂阻滞期间,机械上独立的滑丝和死亡途径之间的随机竞争决定了细胞命运。

Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest.

机构信息

Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2010 Dec 21;5(12):e15724. doi: 10.1371/journal.pone.0015724.

DOI:10.1371/journal.pone.0015724
PMID:21203573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3006339/
Abstract

Variability in cell-to-cell behavior within clonal populations can be attributed to the inherent stochasticity of biochemical reactions. Most single-cell studies have examined variation in behavior due to randomness in gene transcription. Here we investigate the mechanism of cell fate choice and the origin of cell-to-cell variation during mitotic arrest, when transcription is silenced. Prolonged mitotic arrest is commonly observed in cells treated with anti-mitotic drugs. Cell fate during mitotic arrest is determined by two alternative pathways, one promoting cell death, the other promoting cyclin B1 degradation, which leads to mitotic slippage and survival. It has been unclear whether these pathways are mechanistically coupled or independent. In this study we experimentally uncoupled these two pathways using zVAD-fmk to block cell death or Cdc20 knockdown to block slippage. We then used time-lapse imaging to score the kinetics of single cells adopting the remaining fate. We also used kinetic simulation to test whether the behaviors of death versus slippage in cell populations where both pathways are active can be quantitatively recapitulated by a model that assumes stochastic competition between the pathways. Our data are well fit by a model where the two pathways are mechanistically independent, and cell fate is determined by a stochastic kinetic competition between them that results in cell-to-cell variation.

摘要

克隆群体中细胞间行为的可变性可以归因于生化反应的固有随机性。大多数单细胞研究都检查了由于基因转录随机性而导致的行为变化。在这里,我们研究了有丝分裂停滞期间细胞命运选择的机制和细胞间变异的起源,此时转录被沉默。有丝分裂停滞是在用抗有丝分裂药物处理的细胞中常见的现象。有丝分裂停滞期间的细胞命运由两种替代途径决定,一种促进细胞死亡,另一种促进细胞周期蛋白 B1 的降解,这导致有丝分裂滑溜和存活。这些途径是否在机制上是偶联的还是独立的尚不清楚。在这项研究中,我们使用 zVAD-fmk 阻断细胞死亡或 Cdc20 敲低阻断滑溜来实验性地分离这两种途径。然后,我们使用延时成像来评分采用剩余命运的单个细胞的动力学。我们还使用动力学模拟来测试在两条途径都活跃的细胞群体中,死亡与滑溜的行为是否可以通过假设途径之间存在随机竞争的模型来定量再现。我们的数据很好地符合这样一种模型,即两条途径在机制上是独立的,细胞命运由它们之间的随机动力学竞争决定,从而导致细胞间的变异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/3dd1c368bf86/pone.0015724.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/0af1a9a72278/pone.0015724.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/c327d432027f/pone.0015724.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/e0f923af0fa5/pone.0015724.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/3dd1c368bf86/pone.0015724.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/0af1a9a72278/pone.0015724.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/c327d432027f/pone.0015724.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/e0f923af0fa5/pone.0015724.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d522/3006339/3dd1c368bf86/pone.0015724.g004.jpg

相似文献

1
Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest.在有丝分裂阻滞期间,机械上独立的滑丝和死亡途径之间的随机竞争决定了细胞命运。
PLoS One. 2010 Dec 21;5(12):e15724. doi: 10.1371/journal.pone.0015724.
2
Mitotic slippage is determined by p31 and the weakening of the spindle-assembly checkpoint.有丝分裂滑走取决于 p31 和纺锤体装配检查点的弱化。
Oncogene. 2020 Mar;39(13):2819-2834. doi: 10.1038/s41388-020-1187-6. Epub 2020 Feb 6.
3
Cyclin-dependent kinase-1 (Cdk1)/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins.细胞周期蛋白依赖性激酶 1(Cdk1)/细胞周期蛋白 B1 通过磷酸化调节抗凋亡 Bcl-2 蛋白来决定有丝分裂阻滞后的细胞命运。
J Biol Chem. 2012 Nov 9;287(46):39193-204. doi: 10.1074/jbc.M112.391854. Epub 2012 Sep 10.
4
ATP depletion during mitotic arrest induces mitotic slippage and APC/C-dependent cyclin B1 degradation.有丝分裂阻滞期间的 ATP 耗竭会诱导有丝分裂滑脱和 APC/C 依赖性细胞周期蛋白 B1 的降解。
Exp Mol Med. 2018 Apr 27;50(4):1-14. doi: 10.1038/s12276-018-0069-2.
5
Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.有丝分裂阻滞后不同肿瘤细胞的细胞命运由滑溜和凋亡阈值之间的平衡决定。
Toxicol Appl Pharmacol. 2012 Feb 1;258(3):384-93. doi: 10.1016/j.taap.2011.11.021. Epub 2011 Dec 9.
6
Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.CDK1-cyclin B1 对 Mcl-1 的磷酸化作用在有丝分裂阻滞期间引发其 Cdc20 依赖性降解。
EMBO J. 2010 Jul 21;29(14):2407-20. doi: 10.1038/emboj.2010.112. Epub 2010 Jun 4.
7
Caspase-3-dependent mitotic checkpoint inactivation by the small-molecule inducers of mitotic slippage SU6656 and geraldol.Caspase-3 依赖性有丝分裂检查点失活由有丝分裂滑溜小分子诱导剂 SU6656 和杰拉尔多醇引起。
Mol Cancer Ther. 2011 May;10(5):839-49. doi: 10.1158/1535-7163.MCT-10-0909. Epub 2011 Mar 25.
8
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.细胞周期检查点激酶Chk2是有丝分裂灾难的负调控因子。
Oncogene. 2004 May 27;23(25):4353-61. doi: 10.1038/sj.onc.1207573.
9
Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit.周期蛋白依赖性激酶 1 的抑制性磷酸化作为有丝分裂退出的补偿机制。
Mol Cell Biol. 2011 Apr;31(7):1478-91. doi: 10.1128/MCB.00891-10. Epub 2011 Jan 24.
10
Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1.纺锤体组装检查点反应的持续需要 cyclin B1 的从头转录和翻译。
PLoS One. 2010 Sep 28;5(9):e13037. doi: 10.1371/journal.pone.0013037.

引用本文的文献

1
Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy.抑制与攻击:微管靶向药物与溶瘤病毒利用互补机制增强抗肿瘤治疗效果。
Genes (Basel). 2024 Sep 11;15(9):1193. doi: 10.3390/genes15091193.
2
Confinement plus myosin-II suppression maximizes heritable loss of chromosomes, as revealed by live-cell ChReporters.活细胞 ChReporters 揭示,封闭培养并抑制肌球蛋白 II 可最大程度地遗传丢失染色体。
J Cell Sci. 2023 Jun 1;136(11). doi: 10.1242/jcs.260753. Epub 2023 Jun 8.
3
Apoptosis as a Barrier against CIN and Aneuploidy.

本文引用的文献

1
Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly.有证据表明,与纺锤体组装相比,有丝分裂退出是更好的癌症治疗靶点。
Cancer Cell. 2009 Oct 6;16(4):347-58. doi: 10.1016/j.ccr.2009.08.020.
2
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis.TRAIL诱导的细胞凋亡中细胞间变异性的非遗传起源
Nature. 2009 May 21;459(7245):428-32. doi: 10.1038/nature08012. Epub 2009 Apr 12.
3
Dynamic proteomics of individual cancer cells in response to a drug.单个癌细胞对药物反应的动态蛋白质组学
细胞凋亡作为对抗宫颈上皮内瘤变和非整倍体的一道屏障。
Cancers (Basel). 2022 Dec 21;15(1):30. doi: 10.3390/cancers15010030.
4
Bcl-xL activity influences outcome of the mitotic arrest.Bcl-xL活性影响有丝分裂停滞的结果。
Front Pharmacol. 2022 Sep 15;13:933112. doi: 10.3389/fphar.2022.933112. eCollection 2022.
5
TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells.TORC1失活促进酵母和人类细胞中依赖后期促进复合物/细胞周期体(APC/C)的有丝分裂期滑脱。
iScience. 2021 Dec 27;25(2):103675. doi: 10.1016/j.isci.2021.103675. eCollection 2022 Feb 18.
6
Using Budding Yeast to Identify Molecules That Block Cancer Cell 'Mitotic Slippage' Only in the Presence of Mitotic Poisons.利用芽殖酵母鉴定仅在有有丝分裂毒物存在的情况下阻断癌细胞“有丝分裂滑溜”的分子。
Int J Mol Sci. 2021 Jul 26;22(15):7985. doi: 10.3390/ijms22157985.
7
Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression.染色质保持蛋白 CHAMP1 通过调节 Mcl-1 的表达在细胞存活中发挥作用。
Cancer Sci. 2021 Sep;112(9):3711-3721. doi: 10.1111/cas.15018. Epub 2021 Jul 16.
8
Abnormal mitosis in reactive astrocytes.反应性星形胶质细胞中的异常有丝分裂。
Acta Neuropathol Commun. 2020 Apr 15;8(1):47. doi: 10.1186/s40478-020-00919-4.
9
Cell-Cycle Cross Talk with Caspases and Their Substrates.细胞周期与 Caspases 及其底物的交互作用。
Cold Spring Harb Perspect Biol. 2020 Jun 1;12(6):a036475. doi: 10.1101/cshperspect.a036475.
10
Rockets, gauges, and pendulums: applying engineering principles to cell biology.火箭、仪表和钟摆:将工程原理应用于细胞生物学。
Mol Biol Cell. 2019 Jul 1;30(14):1635-1640. doi: 10.1091/mbc.E19-02-0100.
Science. 2008 Dec 5;322(5907):1511-6. doi: 10.1126/science.1160165. Epub 2008 Nov 20.
4
Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate.用驱动蛋白-5抑制剂处理的癌细胞和正常细胞的定量实时成像表明,其表型反应和细胞命运存在显著差异。
Mol Cancer Ther. 2008 Nov;7(11):3480-9. doi: 10.1158/1535-7163.MCT-08-0684. Epub 2008 Oct 30.
5
The TRAIL apoptotic pathway in cancer onset, progression and therapy.肿瘤坏死因子相关凋亡诱导配体(TRAIL)凋亡通路在癌症发生、发展及治疗中的作用
Nat Rev Cancer. 2008 Oct;8(10):782-98. doi: 10.1038/nrc2465.
6
Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.在长期暴露于抗有丝分裂药物后,癌细胞表现出显著的细胞内和细胞系间变异。
Cancer Cell. 2008 Aug 12;14(2):111-22. doi: 10.1016/j.ccr.2008.07.002. Epub 2008 Jul 24.
7
Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.低浓度紫杉醇诱导G1期样阻滞的机制:由延长的有丝分裂介导的下一个细胞周期中依赖p53的亚G1期DNA含量阻滞。
Oncogene. 2008 Jul 24;27(32):4402-10. doi: 10.1038/onc.2008.82. Epub 2008 May 12.
8
Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.针对微管和驱动蛋白-5的抗有丝分裂药物反应中的细胞类型差异。
Cancer Res. 2008 May 1;68(9):3269-76. doi: 10.1158/0008-5472.CAN-07-6699.
9
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells.单细胞中外源凋亡调控途径的定量分析。
Mol Cell. 2008 Apr 11;30(1):11-25. doi: 10.1016/j.molcel.2008.02.012.
10
Distinct sequence elements of cyclin B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis.细胞周期蛋白B1的不同序列元件在有丝分裂期间促进其定位于染色质、中心体和动粒。
Mol Biol Cell. 2007 Dec;18(12):4847-58. doi: 10.1091/mbc.e06-06-0539. Epub 2007 Sep 19.